Cardiospire has landed $3.3M in seed funding, marking an early capital injection for the company. The round provides Cardiospire with its first disclosed investment.

Get the full Cardiospire company profile
Access contacts, investors, buying signals & more
Cardiospire has landed $3.3M in seed funding, marking an early capital injection for the company. The round provides Cardiospire with its first disclosed investment.
Portfolio company of Synergy Ventures

KymaThera
KymaThera combines deep scientific insights with disciplined execution to build best-in-class precision medicines. Its accomplished research team has discovered multiple approved medicines to treat cancer and other serious diseases. Drawing on decades of collective drug discovery experience, KymaThera applies a proprietary framework for strategic structure-based drug design to create differentiated small-molecule therapeutics for better patient outcomes.
$80.0M Series b
today

Blaze Energy Technologies
We are shaping the future of maritime shipping by enabling vessels to run on any alternative fuel. By delivering fuel flexibility for both existing fleets and newbuilds, we eliminate fuel lock-in and empower operators to control their fuel strategy and costs.
$6.5M Seed
today
Largest funding rounds in Healthcare on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Kismet Australia | Pre-seed | $42.0B | 2y ago |
| 2 | ![]() Johnson & Johnson United States | Unknown | $7.0B |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Indemni | Seed | $4.0M | today |
| 2 | ![]() Blaze Energy Technologies United States | Seed | $6.5M | today |
| 3 |

Ghost
The world has changed, and media is struggling to change with it. The internet fuelled advertising-driven business models where all that mattered was capturing as many eyeballs as possible. The resulting economy brought us clickbait, outrage, fake news, and a fraught competition for your attention. Today, creators are choosing a new model where they have a direct relationship with an audience who pay a subscription to receive their content. The incentives are aligned, and the audience is the customer, not the product being sold. At Ghost, we're a small team creating a large platform that's redefining how people are publishing online. The opportunity ahead for subscription commerce is hard to overstate, and we're looking for people who can help turn our dream for the future of publishing into a reality.
$11.0M Seed
today
| 1y ago |
| 3 | ![]() Commure United States | Unknown | $6.0B | 1y ago |
| 4 | ![]() Inari Medical United States | Unknown | $4.9B | 1y ago |
| 5 | ![]() MultiPlan United States | Unknown | $4.5B | 1y ago |
![]() TermiX |
| Seed |
| $1.0M |
| today |
| 4 | ![]() Imperial Perps | Seed | $1.5M | today |
| 5 | ![]() Ghost United States | Seed | $11.0M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in Cardiospire and reach their contacts directly.
Start free trialUnlock 8 more key decision-makers at Cardiospire with verified emails and LinkedIn.
Start free trial
Arctech
Recently received

Kull Servicios Informáticos
Recently received

Minta
Recently received